dual amylin and calcitonin receptor agonist (DACRA) Selective long-acting amylin receptor agonist
The dose escalation period represents the most challenging phase, and strategic timing of supportive peptides can ease this transition
N.CapelaM
Extra caution is appropriate in patients with active cancer, recent cancer, unexplained masses, unexplained weight loss, pregnancy, breastfeeding, known allergy to peptide products, active infection, immune compromise, significant liver or kidney disease, active inflammatory or autoimmune disease flares, unusual clotting history, uncontrolled cardiovascular disease, use of chemotherapy or immune-modifying biologic therapy, and competitive athletes subject to anti-doping rules
Supporting you to nourish your skin from within Uncover the potential of MSM benefits for skin health